Azenta, Inc. (NASDAQ: AZTA)

Azenta, Inc. is a leading global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The company supports customers from research and clinical development through commercialization with sample management and automated storage systems as well as genomic services expertise. It offers a broad portfolio that includes sample procurement automated storage systems genomic services sample consumables informatics and data software and sample repository services. Azenta employs approximately 3000 full time part time and contingent workers worldwide and has sales in about 95 countries. Headquartered in Burlington Massachusetts the company operates in North America Asia and Europe.

Azenta generates revenue primarily from the sale of products and services in its two operating segments. The Sample Management Solutions segment sells automated storage systems cryogenic systems consumables instruments controlled rate thawing devices and offers sample repository services including on site and off site storage cold chain logistics bio processing disaster recovery and informatics solutions. The Multiomics segment provides genomic services such as gene sequencing gene synthesis bioinformatics and good laboratory practice regulatory services. Sales are made through a direct sales force for larger systems and services and through distributors for consumables and instruments in emerging markets.

The company operates through the following segments.

• The Sample Management Solutions segment operates as a single business unit offering end to end sample management products and services including Sample Repository Services and Core Products such as Automated Stores Cryogenic Systems Automated Sample Tubes Consumables and Instruments and Controlled Rate Thawing Devices. It provides customers with high level sample quality security availability intelligence and integrity throughout the sample lifecycle delivering complete cold chain of custody capabilities. The segment also offers expert consultation services for experimental design and implementation. Sample Repository Services include on site and off site sample storage cold chain logistics sample transport and collection relocation bio processing solutions disaster recovery and business continuity project management and consulting. Informatics solutions provide sample intelligence software and support laboratory workflow scheduling environmental and temperature monitoring clinical trial and consent management planning data management virtualization and visualization of sample collections. Automated Stores are stand alone systems capable of storing over 20 million samples in temperature ranges from ambient to minus eighty degrees Celsius with high throughput retrieval. Cryogenic Systems provide cryogenic storage from high efficiency liquid nitrogen vapor based freezers to fully automated systems preserving sample integrity and chain of custody. Automated Sample Tubes offer automation friendly storage tubes with coding options such as 2D coded dual coded and tri coded with external or internal threading and instruments for faster reading capping and de capping. Consumables and Instruments include a complete range of consumables such as racks tubes caps plates and foils used for storage and handling of samples in ambient to ultracold environments together with instruments for labeling bar coding capping de capping auditing sealing peeling and piercing tubes and plates. Controlled Rate Thawing Devices provide automated thawing of plasma blood stem cells and are used in cell and gene therapy applications research development clinical trials good manufacturing practices and hospital settings.

• The Multiomics segment operates as a single business unit offering genomic and other sample analysis services including gene sequencing gene synthesis and related services. It provides a comprehensive global portfolio that enables customers to select solutions for research and development challenges in areas such as cell and gene therapy antibody development and biomarker discovery. Genomic Services include Next Generation sequencing Sanger sequencing gene synthesis bioinformatics and good laboratory practice regulatory services. Sequencing services are available with standard or custom options for extraction library preparation sequencing and bioinformatics supported by Ph D level project managers offering consultation updates and post delivery assistance. Gene synthesis offerings produce a wide range of sequence lengths and structural complexity including DNA cloning gene fragment synthesis oligo synthesis and plasmid purification. The segment also adds value to drug discovery and development by expanding its portfolio to include proteomics solutions and regulated services targeting analysis of adenoassociated virus a common vector used in cell and gene therapy.

Azenta holds a strong position in the life sciences sample management and genomics markets competing with several established players. In the Sample Management Solutions segment its main competitors include Hamilton Company and Liconic AG for automation systems and Laboratory Corporation of America Holdings and Thermo Fisher Scientific for storage consumables and services. In the Multiomics segment its main competitors include BGI Genomics Co Ltd Eurofins Scientific SE GenScript Biotech Corporation Integrated DNA Technologies Inc Novogene Co Ltd and Twist Bioscience Corporation. The company differentiates itself through its broad end to end product and service portfolio its global footprint spanning approximately 95 countries its precision automation and cryogenics expertise and its ability to provide integrated solutions from sample storage to genomic analysis. These strengths allow Azenta to serve as a trusted partner for pharmaceutical biotechnology and life sciences research institutions seeking to accelerate therapy development.

Azenta serves approximately 14000 customers globally ranging from top pharmaceutical and biotechnology companies to advanced research hospitals academic and government institutions and emerging biotech start ups. While the filing does not disclose specific customer names the base includes major drug developers leading clinical research centers and prominent university laboratories. The company believes its broad customer base provides opportunities for further expansion and deeper relationships across the life sciences ecosystem.